GLP-1 (glucagon-like peptide-1) medications are injectable drugs that mimic a natural hormone your body already makes to regulate appetite and blood sugar
The Ozempic Lawsuit focuses on claims that the diabetes and weight loss medication, Ozempic, has caused severe gastrointestinal issues, including gastroparesis (paralysis of the stomach), nausea, vomiting, and other serious side effects
Total Fat: 3g
Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia
Microdosing is custom-titrated at significantly lower levels based on response, tolerability, and metabolic goals, making it a more precise and often better-tolerated approach
The news: Eli Lilly is launching Lilly Employer Connect, a direct-to-employer platform for its obesity drug Zepbound, offering flat pricing for companies